OTC Pharmaceuticals - Tanzania

  • Tanzania
  • The OTC Pharmaceuticals market in Tanzania is projected to generate a revenue of US$201.90m in 2024.
  • It is expected to experience an annual growth rate of 9.12% (CAGR 2024-2029).
  • Among the various markets, the largest one is Vitamins & Minerals, which is estimated to reach a market volume of US$60.67m in 2024.
  • In terms of global comparison, the in the United States leads the way with revenue amounting to US$41,240.00m in the same year.
  • When considering the population size, per person revenues of US$2.91 are projected for Tanzania in 2024.
  • Additionally, online sales are predicted to contribute 4.32% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • Tanzania's OTC Pharmaceuticals market is experiencing a growing demand for traditional herbal remedies among its population.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Tanzania is experiencing significant growth and development.

Customer preferences:
Customers in Tanzania are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This can be attributed to several factors, including the convenience and accessibility of OTC products. With the rise of self-medication and increasing awareness about healthcare, consumers are seeking OTC medications to treat common ailments and minor health issues. Additionally, the affordability of OTC products compared to prescription drugs is also a driving factor for customer preferences.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Tanzania is the growing demand for herbal and traditional medicines. Tanzanian consumers have a long-standing tradition of using natural remedies for various health conditions. This trend is driven by the perception that herbal medicines are safer and have fewer side effects compared to synthetic drugs. As a result, there has been an increase in the availability and sales of herbal and traditional OTC products in the market.Another trend in the market is the expansion of the retail pharmacy sector. With the increasing demand for OTC medications, there has been a proliferation of retail pharmacies across Tanzania. This expansion is driven by factors such as urbanization, population growth, and increasing healthcare awareness. The presence of retail pharmacies provides consumers with easy access to a wide range of OTC products and professional advice from pharmacists.

Local special circumstances:
Tanzania has a diverse population with varying healthcare needs and preferences. The country is home to different ethnic groups, each with its own traditional medicine practices and beliefs. This diversity influences the demand for OTC pharmaceuticals, as consumers may prefer certain products or remedies based on their cultural background. Therefore, pharmaceutical companies operating in Tanzania need to consider these local special circumstances and tailor their product offerings accordingly.

Underlying macroeconomic factors:
The growth of the OTC Pharmaceuticals market in Tanzania can also be attributed to favorable macroeconomic factors. The country has experienced steady economic growth in recent years, which has resulted in an increase in disposable income levels. As a result, consumers have more purchasing power and are willing to spend on healthcare products, including OTC medications. Additionally, the government's efforts to improve healthcare infrastructure and services have also contributed to the development of the OTC Pharmaceuticals market.In conclusion, the OTC Pharmaceuticals market in Tanzania is witnessing significant growth and development. Customer preferences for convenience, affordability, and herbal medicines are driving the demand for OTC products. The expansion of the retail pharmacy sector and the presence of diverse cultural practices also contribute to the market trends. Favorable macroeconomic factors, such as economic growth and government initiatives, further support the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)